BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33291857)

  • 1. Prevalence of Newly Diagnosed Malignancies in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis, Comparison of 18F-FDG PET/CT Scan with Chest X-ray and Abdominal Ultrasound: Data from a 40 Week Prospective, Exploratory, Single Centre Study.
    Emamifar A; Hess S; Ellingsen T; Due Kay S; Christian Bang J; Gerke O; Syrak Hansen P; Ahangarani Farahani Z; Petersen H; Marcussen N; Jensen Hansen IM; Thye Rønn P
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33291857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of 18F-FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross-sectional Study.
    Emamifar A; Ellingsen T; Hess S; Gerke O; Hviid Larsen R; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Petersen H; Marcussen N; Dahlstrøm M; Toftegaard P; Thye-Rønn P
    ACR Open Rheumatol; 2020 Aug; 2(8):478-490. PubMed ID: 33439554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
    Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
    Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis.
    Heras-Recuero E; Martínez de Bourio-Allona M; Landaeta-Kancev LC; Blázquez-Sánchez T; Torres-Roselló A; Álvarez-Rubio M; Belhaj-Gandar M; Martínez-López JA; Martínez-Dhier L; Llorca J; Largo R; González-Gay MÁ
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants.
    Colaci M; Dichiara J; Aprile ML; Ippolito M; Schinocca C; Guggino G; Malatino L
    Front Med (Lausanne); 2022; 9():1042620. PubMed ID: 36465900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Body [
    Fröhlich M; Serfling S; Higuchi T; Pomper MG; Rowe SP; Schmalzing M; Tony HP; Gernert M; Strunz PP; Portegys J; Schwaneck EC; Gadeholt O; Weich A; Buck AK; Bley TA; Guggenberger KV; Werner RA
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT.
    Gorlen TF; Brittain JM; Østergaard M; Fischer BM; Døhn UM; Terslev L
    Front Med (Lausanne); 2024; 11():1309905. PubMed ID: 38449885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of positive
    Prieto-Peña D; Martínez-Rodríguez I; Loricera J; Banzo I; Calderón-Goercke M; Calvo-Río V; González-Vela C; Corrales A; Castañeda S; Blanco R; Hernández JL; González-Gay MÁ
    Semin Arthritis Rheum; 2019 Feb; 48(4):720-727. PubMed ID: 29903537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study.
    Burg LC; Karakostas P; Behning C; Brossart P; Kermani TA; Schäfer VS
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149963. PubMed ID: 36777696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of
    Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
    J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Clinical Uncertainty Solved: Giant Cell Arteritis with Polymyalgia Rheumatica Swiftly Diagnosed with Long Axial Field of View PET.
    Nienhuis PH; van Sluis J; van Snick JH; Glaudemans AWJM; Meijering S; Brouwer E; Slart RHJA
    Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
    Iannuzzi F; Hysa E; Camellino D; Morbelli S; Bauckneht M; Sambuceti G; Cutolo M; Cimmino MA
    Clin Exp Rheumatol; 2023 Apr; 41(4):812-820. PubMed ID: 37073635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography.
    Cimmino MA; Camellino D; Paparo F; Morbelli S; Massollo M; Cutolo M; Sambuceti G
    Rheumatology (Oxford); 2013 Oct; 52(10):1865-72. PubMed ID: 23850896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.
    Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T
    Semin Arthritis Rheum; 2022 Aug; 55():152017. PubMed ID: 35537222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
    Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
    Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Allard B; Devauchelle-Pensec V; Saraux A; Nowak E; Tison A; Boukhlal S; Guellec D; Jousse-Joulin S; Cornec D; Marhadour T; Le Pennec R; Salaün PY; Querellou S
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1297-1309. PubMed ID: 38095675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
    Nielsen AW; Frølund LL; Våben C; Bonde AR; Gormsen LC; de Thurah AL; Hauge EM; Keller KK
    Semin Arthritis Rheum; 2022 Oct; 56():152069. PubMed ID: 35858507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.
    Slart RHJA; ; ; ; ; ; ; ;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1250-1269. PubMed ID: 29637252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica.
    Manzo C; Castagna A; Veronese N; Isetta M
    Reumatologia; 2023; 61(6):432-438. PubMed ID: 38322103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.